Catalent | CTLT - Capitale Ordinario



Capitale Ordinario Cambiamento Data
Agilent USD 282.7M 358K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Bruker USD 151.94M 225K 2025-12
Centene USD 491.76M 343K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Cigna USD 263.46M 3.14M 2025-12
Danaher USD 706.9M 600K 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Elevance Health USD 222.24M 2.94M 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Glaxosmithkline GBP 4.03B 2.68B 2025-09
Hologic USD 222.57M 350K 2025-09
Humana USD 120.59M 318K 2025-12
Illumina USD 152.8M 900K 2025-12
Intuitive Surgical USD 354.5M 3.98M 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
J&J USD 2.41B 584K 2025-09
Laboratory Of America USD 82.2M 700K 2025-12
Lonza CHF 72M 0 2024-12
McKesson USD 280M 156M 2025-12
Merck EUR 434.78M 0 2025-12
Merck USD 2.49B 15.79M 2025-09
Mettler Toledo International USD 20.43M 170.6K 2025-12
Novartis USD 1.94B 23.4M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Quest Diagnostics USD 110M 1000K 2025-12
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
UnitedHealth USD 905.84M 161K 2025-12
Veradigm USD 2.79M 4K 2022-09
Waters USD 98.08M 38.55M 2025-12
West Pharmaceutical Services USD 72M 100K 2025-12